T helper 17 cell

Feb 25, 2020

InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal

Sep 18, 2019

Immunic, Inc. Doses First Healthy Volunteer in its Phase 1 Clinical Program of IMU-935, a Potentially Best-in-Class RORgt Inverse Agonist

Aug 01, 2019

Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project

Jul 26, 2019

Th17 Inflammatory Pathway Therapeutics Markets, 2022

Feb 05, 2019

Predictive Markers of Survival Identified for Next Generation Cancer Stem Cell Vaccine

Oct 18, 2018

Oral DS107 Found to Reverse the Molecular Signature of Moderate to Severe Atopic Dermatitis Patients in a Phase 2 Trial

Aug 22, 2018

Nuevolution Discloses the Identity of its "Cytokine X" Program being Interleukin IL-17A and Initiates Promotion of its Small Molecule IL-17A Inhibitor Program Targeting Inflammatory Diseases

Dec 01, 2017

InDex Pharmaceuticals Reports New Mechanism of Action Data for Cobitolimod